Drakes Supermarkets giving patients with advanced cancers the best chance of survival
Ryan Hodges and Dr Madelé van Dyk pictured with Wendy Drake, Flinders Foundation Executive Director, Ross Verschoor, and Roger Drake at the Drakes Charity Showbag morning tea
Drakes Supermarkets are giving patients with advanced cancers the best chance of survival and precious time to spend with their loved ones.
Flinders Foundation has been a grateful beneficiary of Drakes’ Charity Showbag for many years.
From the 2020 sales of the popular showbag, $13,649 was recently donated to support precision dosing cancer research at Flinders.
This funding will support research in Dr Madelé van Dyk’s laboratory, where the team is helping around 200 patients with advanced cancers who are receiving ‘targeted therapy’ by moving away from the ‘one-size-fits-all’ approach, and towards each patient receiving a personalised dose tailored to their own body.
Unlike more traditional cancer treatments such as chemotherapy and radiotherapy which target all cells in the body - including healthy cells - ‘targeted therapies’ are unique in that they target specific proteins involved in the cancer cells and block both the blood and nutrient supply to the tumour and tumour growth.
Getting the “right amount of drug” to the patient is crucial, and through research a defined ‘target concentration’ has been identified to indicate how much of the drugs patients should receive. But as these drugs are taken orally at a ‘one-size fits-all’ dose, and each patient metabolises and absorbs the drug differently, blood concentrations can differ 20-100 per cent between patients.
“Body type, age, genetics, gender, ethnicity and drug metabolism are all factors which affect how much of the drug you end up with in your body,” Dr van Dyk explains.
“This concentration level is important because it’s the amount of drug the tumour will be exposed to – if it’s not enough, then the tumour won’t stop growing and if it’s too much then it can be incredibly toxic for the patient.”
Via a simple blood sample, Dr van Dyk’s team have developed methods to determine the end concentration of the drug in each individual patient. By passing these results on to the patient’s oncologist, the drug levels can be monitored and doses can be increased or decreased to optimise their treatment.
“We want to get rid of the ‘one-size-fits-all’ approach and come up with a personalised approach for every patient to make sure they get the dose their body needs to give them the best chance of benefiting from the treatment,” Dr Van Dyk says.
“That means the best quality of life and the best chance of survival while minimising the toxicity they’re exposed to.”
This generous support from Drakes will help the research team work with oncologists to help implement personalised dosing for more patients, like 38-year-old Ryan Hodges.
Living with stage 4 lung cancer, Ryan was one of the first patients involved in Dr van Dyk’s personalised dosing studies six years ago and since then he’s dedicated much of his free time to raising funds for research into precision dosing and targeted cancer therapies.
Ryan and Dr van Dyk were guests of Drakes Supermarkets’ Charity Showbag morning tea, sharing with those in attendance how Drakes’ support will help give more patients like Ryan the best chance of survival and precious time to spend with son Ollie and wife Helen.
This is the first research of its kind in South Australia - something South Australian company Drakes Supermarkets is proud to support.
Thank you to Drakes and their wonderful suppliers and customers for making a difference for patients and their families affected by cancer.
‘Taking Charge’ of Long Covid
One year on from her Covid-19 diagnosis, she still lives with the often-debilitating symptoms of Post Covid-19 condition – commonly known as ‘long covid’.
A novel blood test which could be used to monitor the treatment of lung cancer
Flinders Medical Centre Senior Consultant, Dr Anand Rose, has received a Southern Adelaide Local Health Network (SALHN) Enquiry Grant for research into a novel blood test which could be used to monitor the treatment of lung cancer – the most common cause of cancer-related death in Australia.
Stroke Rehab goes Virtual
Researchers from Flinders University and UniSA are set to develop a new rehabilitation technique for stroke survivors using state-of-the-art Virtual Reality (VR) technology.
New Hope for Pancreatic Cancer
Dr Jean Winter and her Flinders University research team will soon begin trials of a world-first blood biomarker test for patients with pancreatic cancer.
Help for families in gambling battle
The Southern Adelaide Local Health Network’s (SALHN) Statewide Gambling Therapy Service provides psychological therapies to individuals with gambling addictions.
Rapid access to surgical procedures
Podiatrists at Noarlunga Hospital will trial a new model of care for anxious patients, to help them get rapid access to some minor surgical procedures.
$1 Million in grants awarded
$1 million in grants awarded to 23 health and medical research projects across Southern Adelaide
31 New Health and Medical Research Projects
Health and medical researchers across the Flinders Medical Precinct will share in $750,000 funding, to support exciting research projects across a variety of illnesses, diseases, and social issues.
Grateful Tony Gives Back
Struggling to get a breath in and feeling like he was “choking to death”, Tony de Maaijer knew he was in a bad way.
New Funding for Cancer Research
World Cancer Day (February 4) marked the announcement of funding for four new cancer research projects thanks to the generosity of guests and supporters of Flinders Foundation’s Pink Yellow Blue Enchanted Garden event.